Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat ...

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Also known as the "stomach bug" or "stomach flu," norovirus causes acute gastroenteritis, the CDC said, inflaming the stomach ...